0001213900-23-093858.txt : 20231206 0001213900-23-093858.hdr.sgml : 20231206 20231206214507 ACCESSION NUMBER: 0001213900-23-093858 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231204 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Exploration Capital Fund, LP CENTRAL INDEX KEY: 0001799866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 231470965 BUSINESS ADDRESS: STREET 1: 250 EAST 200 SOUTH STREET 2: FLOOR 16 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 BUSINESS PHONE: 2122204444 MAIL ADDRESS: STREET 1: 250 EAST 200 SOUTH STREET 2: FLOOR 16 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Exploration Capital, LLC CENTRAL INDEX KEY: 0002003514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 231470964 BUSINESS ADDRESS: STREET 1: 250 EAST 200 SOUTH, FLOOR 16 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 BUSINESS PHONE: (212) 220-4444 MAIL ADDRESS: STREET 1: 250 EAST 200 SOUTH, FLOOR 16 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Exploration Capital General Partner, LLC CENTRAL INDEX KEY: 0002003481 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 231470963 BUSINESS ADDRESS: STREET 1: 250 EAST 200 SOUTH, FLOOR 16 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 BUSINESS PHONE: (212) 220-4444 MAIL ADDRESS: STREET 1: 250 EAST 200 SOUTH, FLOOR 16 CITY: SALT LAKE CITY STATE: UT ZIP: 84111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Brickell Biotech, Inc. DATE OF NAME CHANGE: 20190830 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 marketforms-63736.xml PRIMARY DOCUMENT X0508 4 2023-12-04 0000819050 Fresh Tracks Therapeutics, Inc. FRTX 0001799866 Exploration Capital Fund, LP 250 EAST 200 SOUTH FLOOR 16 SALT LAKE CITY UT 84111 false false true false 0002003514 Exploration Capital, LLC 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 false false true false 0002003481 Exploration Capital General Partner, LLC 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 false false true false 0 Common Stock 2023-12-04 4 P false 7579 0.85 D 677579 D Common Stock 2023-12-05 4 P false 5188 0.85 D 682767 D Common Stock 2023-12-06 4 P false 17233 0.90 D 700000 D Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest. Stephen L. Gustin on behalf of Exploration Capital Fund, LP 2023-12-06 Stephen L. Gustin on behalf of Exploration Capital, LLC 2023-12-06 Stephen L. Gustin on behalf of Exploration Capital General Partner, LLC 2023-12-06